SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-087127
Filing Date
2024-07-29
Accepted
2024-07-29 08:38:58
Documents
122
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 20-F ipa-20240430.htm   iXBRL 20-F 5232012
2 EX-2.1 ipa-ex2_1.htm EX-2.1 10518
3 EX-2.2 ipa-ex2_2.htm EX-2.2 226249
4 EX-4.5 ipa-ex4_5.htm EX-4.5 371745
5 EX-4.6 ipa-ex4_6.htm EX-4.6 155949
6 EX-4.7 ipa-ex4_7.htm EX-4.7 39795
7 EX-8.1 ipa-ex8_1.htm EX-8.1 13498
8 EX-12.1 ipa-ex12_1.htm EX-12.1 15524
9 EX-12.2 ipa-ex12_2.htm EX-12.2 14637
10 EX-13.1 ipa-ex13_1.htm EX-13.1 10094
11 EX-13.2 ipa-ex13_2.htm EX-13.2 9875
12 EX-15.1 ipa-ex15_1.htm EX-15.1 2758
13 EX-97.1 ipa-ex97_1.htm EX-97.1 45159
14 GRAPHIC img154269876_0.jpg GRAPHIC 53319
  Complete submission text file 0000950170-24-087127.txt   21681045

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ipa-20240430.xsd EX-101.SCH 2152077
124 EXTRACTED XBRL INSTANCE DOCUMENT ipa-20240430_htm.xml XML 5330996
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 20-F | Act: 34 | File No.: 001-39530 | Film No.: 241149109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)